Javascript must be enabled to continue!
Pharmacodynamic Interactions Between Infused Adenosine and Oral Theophylline
View through CrossRef
1 Five healthy human subjects were given, in single-blind fashion, either (a) 625 mg theophylline orally, followed 4 h later, by a 40 min infusion of adenosine (40 μg kg
-1
min
-1
for 5 min, 60 μg kg
-1
min
-1
for 5 min and 80 μg kg
-1
min
-1
for 30 min), or (b) 625 mg theophylline orally followed by 0.9% sodium chloride infusion, or (c) placebo theophylline tablets followed by adenosine infusion.
2 All five subjects experienced adverse effects during adenosine infusion, mainly at the higher infusion rates; two subjects also experienced chest pain but not during combined treatment with theophylline and adenosine.
3 Diastolic blood pressure (DBP) rose by 16.5 mmHg ( P < 0.001) following treatment with theophylline only, fell by 24.5 mmHg ( P < 0.001) during the adenosine infusion after placebo theophylline and remained unchanged during the adenosine infusion following theophylline. Pulse rate rose by 12 min
-1
( P < 0.01) during adenosine infusion following placebo, but not after theophylline alone or theophylline and adenosine combined.
4 The respiratory rate fell by 6 min
-1
( P < 0.01) during treatment with adenosine only, being lower than for the two treatments containing theophylline ( P < 0.05).
5 Plasma potassium and magnesium fell by 0.25 mmol I
-1
( P < 0.001) and 0.037 mmol I
-1
( P < 0.05), respectively, during treatment with theophylline only, but these effects were not altered by infusion of adenosine.
6 This study has demonstrated interactions between theophylline and adenosine on diastolic blood pressure and respiratory rate, but no interaction on metabolic parameters. Adenosine infusion is unlikely to be of value in the management of theophylline toxicity, but its effects on theophylline-induced cardiac arrhythmias remain unexplored.
Title: Pharmacodynamic Interactions Between Infused Adenosine and Oral Theophylline
Description:
1 Five healthy human subjects were given, in single-blind fashion, either (a) 625 mg theophylline orally, followed 4 h later, by a 40 min infusion of adenosine (40 μg kg
-1
min
-1
for 5 min, 60 μg kg
-1
min
-1
for 5 min and 80 μg kg
-1
min
-1
for 30 min), or (b) 625 mg theophylline orally followed by 0.
9% sodium chloride infusion, or (c) placebo theophylline tablets followed by adenosine infusion.
2 All five subjects experienced adverse effects during adenosine infusion, mainly at the higher infusion rates; two subjects also experienced chest pain but not during combined treatment with theophylline and adenosine.
3 Diastolic blood pressure (DBP) rose by 16.
5 mmHg ( P < 0.
001) following treatment with theophylline only, fell by 24.
5 mmHg ( P < 0.
001) during the adenosine infusion after placebo theophylline and remained unchanged during the adenosine infusion following theophylline.
Pulse rate rose by 12 min
-1
( P < 0.
01) during adenosine infusion following placebo, but not after theophylline alone or theophylline and adenosine combined.
4 The respiratory rate fell by 6 min
-1
( P < 0.
01) during treatment with adenosine only, being lower than for the two treatments containing theophylline ( P < 0.
05).
5 Plasma potassium and magnesium fell by 0.
25 mmol I
-1
( P < 0.
001) and 0.
037 mmol I
-1
( P < 0.
05), respectively, during treatment with theophylline only, but these effects were not altered by infusion of adenosine.
6 This study has demonstrated interactions between theophylline and adenosine on diastolic blood pressure and respiratory rate, but no interaction on metabolic parameters.
Adenosine infusion is unlikely to be of value in the management of theophylline toxicity, but its effects on theophylline-induced cardiac arrhythmias remain unexplored.
Related Results
Analgesic effects of adenosine in Syndrome X are counteracted by theophylline: a double-blind placebo-controlled study
Analgesic effects of adenosine in Syndrome X are counteracted by theophylline: a double-blind placebo-controlled study
It has been proposed that adenosine mediates ischaemic pain in humans. Patients with cardiac Syndrome X are hypersensitive to potential pain stimuli, including adenosine. On the ot...
AI-infused patients for enhanced clinical simulation
AI-infused patients for enhanced clinical simulation
Artificial intelligence (AI) refers to the simulation of human intelligence in computers, allowing them to perform tasks that usually require human cognitive abilities, such as dec...
Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma
BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as s...
020 Comparison of fractional flow reserve measurements obtained using central vs distal peripheral intravenous adenosine infusion to induce hyperaemia
020 Comparison of fractional flow reserve measurements obtained using central vs distal peripheral intravenous adenosine infusion to induce hyperaemia
Introduction
Measurement of fractional flow reserve (FFR) permits physiological evaluation of coronary lesions. Maximal hyperaemia is required and adenosine is mo...
Methylxanthines
Methylxanthines
Abstract
The closely related alkaloids caffeine (from Coffea arabica, but also present in tea, mate leaves, and cola nuts), theoph ylline (from Thea sinensis), an...
A Case Report of Severe Theophylline Poisoning: Management and Review of Literature
A Case Report of Severe Theophylline Poisoning: Management and Review of Literature
Background Theophylline poisoning leads to multisystem toxicity. Management of theophylline overdose is focused on stabilizing cardiovascular manifestations of arrhythmia and hypot...
Ectonucléotidases, adénosine et transmission synaptique
Ectonucléotidases, adénosine et transmission synaptique
Dans le cerveau, les fonctions de la phosphatase alcaline non spécifique des tissus (TNAP) ne sont pas clairement identifiées. La localisation et l'expression de cette enzyme au ni...
Adenosine Promotion of Cellular Migration in Bronchial Epithelial Cells is Mediated by the Activation of Cyclic Adenosine Monophosphate–Dependent Protein Kinase A
Adenosine Promotion of Cellular Migration in Bronchial Epithelial Cells is Mediated by the Activation of Cyclic Adenosine Monophosphate–Dependent Protein Kinase A
Migration of neighboring cells into the injury is important for rapid repair of damaged airway epithelium. We previously reported that activation of the A
2A
...

